Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

"data availability the raw scrna+tcr??-seq data generated in this study are available in the european genome-phenome archive under accession code egas00001005044. the processed scrna+tcr??-seq data and the seurat-objects are available at zenodo under 10 5281/zenodo 7330586.; the processed tcr?-seq data including the pr1-classifier for tcrgp are available at zenodo under 10 5281/zenodo 7330586. supplementary figures and supplementary data legends supplementary data 1 supplementary data 2 supplementary data 3 supplementary data 4 publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. data availability the raw scrna+tcr??-seq data generated in this study are available in the european genome-phenome archive under accession code egas00001005044"

"code availability the code to reproduce the key findings is available at https://github com/janihuuh/cml_stop_manu ."

"Competing interests P.D. is currently employed by Nygen Analytics AB. M.I. is currently employed by Bristol Myers Squibb. U.O.S. has received honoraria from Incyte. H.H.H. has received honoraria from Novartis, Bristol Myers Squibb, and Incyte. A.B. has received honoraria from Novartis and MSD. G.K. is currently employed by Nygen Analytics AB. A.K. is currently employed by Bristol Myers Squibb. S.M. has received honoraria from Bristol Myers Squibb and DrenBio and research funding from BMS, Novartis, and Pfizer. All other authors declare no conflicts of interests."

"Funding Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital)."